{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:20:24Z","timestamp":1762867224055,"version":"3.40.3"},"publisher-location":"Dordrecht","reference-count":28,"publisher":"Springer Netherlands","isbn-type":[{"type":"print","value":"9789402410778"},{"type":"electronic","value":"9789402410792"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-94-024-1079-2_55","type":"book-chapter","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T04:54:12Z","timestamp":1503896052000},"page":"703-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Taurine Administration Mitigates Cisplatin Induced Acute Nephrotoxicity by Decreasing DNA Damage and Inflammation: An Immunocytochemical Study"],"prefix":"10.1007","author":[{"given":"Masahiro","family":"Tsunekawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenori","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"5","key":"55_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","volume":"23","author":"I Arany","year":"2003","unstructured":"Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23(5):460\u2013464. S0270929503000895 [pii]","journal-title":"Semin Nephrol"},{"issue":"2","key":"55_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/jpet.110.165779","volume":"334","author":"S Camano","year":"2010","unstructured":"Camano S, Lazaro A, Moreno-Gordaliza E, Torres AM, de Lucas C, Humanes B, Lazaro JA, Milagros Gomez-Gomez M, Bosca L, Tejedor A (2010) Cilastatin attenuates cisplatin-induced proximal tubular cell damage. J Pharmacol Exp Ther 334(2):419\u2013429. doi:10.1124\/jpet.110.165779. jpet.110.165779 [pii]","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"55_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.etp.2008.09.003","volume":"61","author":"YI Chirino","year":"2009","unstructured":"Chirino YI, Pedraza-Chaverri J (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 61(3):223\u2013242. doi:10.1016\/j.etp.2008.09.003. S0940-2993(08)00138-3 [pii]","journal-title":"Exp Toxicol Pathol"},{"issue":"12","key":"55_CR4","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.V12122683","volume":"12","author":"CA Davis","year":"2001","unstructured":"Davis CA, Nick HS, Agarwal A (2001) Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12(12):2683\u20132690","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"55_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1124\/jpet.107.119792","volume":"322","author":"S Faubel","year":"2007","unstructured":"Faubel S, Lewis EC, Reznikov L, Ljubanovic D, Hoke TS, Somerset H, Oh DJ, Lu L, Klein CL, Dinarello CA, Edelstein CL (2007) Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther 322(1):8\u201315. doi:10.1124\/jpet.107.119792. jpet.107.119792 [pii]","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"55_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/oxfordjournals.annonc.a058125","volume":"3","author":"R Fontanelli","year":"1992","unstructured":"Fontanelli R, Spatti G, Raspagliesi F, Zunino F, Di Re F (1992) A preoperative single course of high-dose cisplatin and bleomycin with glutathione protection in bulky stage IB\/II carcinoma of the cervix. Ann Oncol 3(2):117\u2013121","journal-title":"Ann Oncol"},{"issue":"1","key":"55_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tox.2006.10.025","volume":"230","author":"HD Francescato","year":"2007","unstructured":"Francescato HD, Costa RS, Scavone C, Coimbra TM (2007) Parthenolide reduces cisplatin-induced renal damage. Toxicology 230(1):64\u201375. doi:10.1016\/j.tox.2006.10.025. S0300-483X(06)00638-X [pii]","journal-title":"Toxicology"},{"key":"55_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/0-306-46838-7_59","volume":"483","author":"SN Giri","year":"2000","unstructured":"Giri SN, Gurujeyalakshmi G, Wang Y (2000) Suppression of bleomycin-induced increased production of nitric oxide and NF-kB activation by treatment with taurine and niacin. Adv Exp Med Biol 483:545\u2013561. doi:10.1007\/0-306-46838-7_59","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"55_CR9","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1186\/1423-0127-17-S1-S28","volume":"17","author":"X Han","year":"2010","unstructured":"Han X, Chesney RW (2010) Stress-responsive gene TauT and acute kidney injury. J Biomed Sci 17(Suppl 1):S28. doi:10.1186\/1423-0127-17-S1-S28. 1423-0127-17-S1-S28 [pii]","journal-title":"J Biomed Sci"},{"issue":"1\u20132","key":"55_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1748-1716.2006.01573.x","volume":"187","author":"X Han","year":"2006","unstructured":"Han X, Patters AB, Jones DP, Zelikovic I, Chesney RW (2006) The taurine transporter: mechanisms of regulation. Acta Physiol (Oxford) 187(1\u20132):61\u201373. doi:10.1111\/j.1748-1716.2006.01573.x. APS1573 [pii]","journal-title":"Acta Physiol (Oxford)"},{"key":"55_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-0-387-33504-9_13","volume":"583","author":"SH Hansen","year":"2006","unstructured":"Hansen SH, Andersen ML, Birkedal H, Cornett C, Wibrand F (2006) The important role of taurine in oxidative metabolism. Adv Exp Med Biol 583:129\u2013135","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"55_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0006-291X(90)92345-Z","volume":"168","author":"Y Hosokawa","year":"1990","unstructured":"Hosokawa Y, Matsumoto A, Oka J, Itakura H, Yamaguchi K (1990) Isolation and characterization of a cDNA for rat liver cysteine dioxygenase. Biochem Biophys Res Commun 168(2):473\u2013478. 0006-291X(90)92345-Z [pii]","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"55_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/00004872-199406000-00005","volume":"12","author":"M Ideishi","year":"1994","unstructured":"Ideishi M, Miura S, Sakai T, Sasaguri M, Misumi Y, Arakawa K (1994) Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. J Hypertens 12(6):653\u2013661","journal-title":"J Hypertens"},{"key":"55_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/978-0-387-33504-9_55","volume":"583","author":"C Kim","year":"2006","unstructured":"Kim C, Choi HS, Kim JW (2006) Taurine chloramine inhibits the production of nitric oxide and superoxide anion by modulating specific mitogen-activated protein kinases. Adv Exp Med Biol 583:493\u2013498","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"55_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/apha.12365","volume":"213","author":"IH Lambert","year":"2014","unstructured":"Lambert IH, Kristensen DM, Holm JB, Mortensen OH (2014) Physiological role of taurine--from organism to organelle. Acta Physiol (Oxford) 213(1):191\u2013212. doi:10.1111\/apha.12365","journal-title":"Acta Physiol (Oxford)"},{"issue":"5","key":"55_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.7326\/0003-4819-100-5-704","volume":"100","author":"PJ Loehrer","year":"1984","unstructured":"Loehrer PJ, Einhorn LH (1984) Drugs five years later. Cisplatin Ann Intern Med 100(5):704\u2013713","journal-title":"Cisplatin Ann Intern Med"},{"issue":"5","key":"55_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/42.5.7908911","volume":"42","author":"N Ma","year":"1994","unstructured":"Ma N, Aoki E, Semba R (1994) An immunohistochemical study of aspartate, glutamate, and taurine in rat kidney. J Histochem Cytochem 42(5):621\u2013626","journal-title":"J Histochem Cytochem"},{"issue":"14","key":"55_CR18","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1016\/j.febslet.2005.04.063","volume":"579","author":"T Mochizuki","year":"2005","unstructured":"Mochizuki T, Satsu H, Shimizu M (2005) Signaling pathways involved in tumor necrosis factor alpha-induced upregulation of the taurine transporter in Caco-2 cells. FEBS Lett 579(14):3069\u20133074. doi:10.1016\/j.febslet.2005.04.063. S0014-5793(05)00540-5 [pii]","journal-title":"FEBS Lett"},{"issue":"2","key":"55_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.ki.5001503","volume":"70","author":"MS Mozaffari","year":"2006","unstructured":"Mozaffari MS, Patel C, Abdelsayed R, Schaffer SW (2006) Accelerated NaCl-induced hypertension in taurine-deficient rat: role of renal function. Kidney Int 70(2):329\u2013337. doi:10.1038\/sj.ki.5001503. S0085-2538(15)51923-6 [pii]","journal-title":"Kidney Int"},{"issue":"5 Suppl 12","key":"55_CR20","first-page":"61","volume":"22","author":"RF Ozols","year":"1995","unstructured":"Ozols RF (1995) Current status of chemotherapy for ovarian cancer. Semin Oncol 22(5 Suppl 12):61\u201366","journal-title":"Semin Oncol"},{"issue":"9","key":"55_CR21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73(9):994\u20131007. doi:10.1038\/sj.ki.5002786. 5002786 [pii]","journal-title":"Kidney Int"},{"issue":"3","key":"55_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0090-8258(91)90310-2","volume":"41","author":"PB Panici","year":"1991","unstructured":"Panici PB, Greggi S, Scambia G, Ragusa G, Baiocchi G, Battaglia F, Coronetta F, Mancuso S (1991) High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: a preliminary report. Gynecol Oncol 41(3):212\u2013216. 0090-8258(91)90310-2 [pii]","journal-title":"Gynecol Oncol"},{"issue":"10","key":"55_CR23","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1016\/j.fct.2011.07.008","volume":"49","author":"JM Perez-Rojas","year":"2011","unstructured":"Perez-Rojas JM, Guerrero-Beltran CE, Cruz C, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Pedraza-Chaverri J (2011) Preventive effect of tert-butylhydroquinone on cisplatin-induced nephrotoxicity in rats. Food Chem Toxicol 49(10):2631\u20132637. doi:10.1016\/j.fct.2011.07.008. S0278-6915(11)00331-0 [pii]","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"55_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0272-6386(86)80112-3","volume":"8","author":"F Ries","year":"1986","unstructured":"Ries F, Klastersky J (1986) Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8(5):368\u2013379. S0272638686001129 [pii]","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"55_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00210-001-0524-8","volume":"365","author":"S Sato","year":"2002","unstructured":"Sato S, Yamate J, Saito T, Hosokawa T, Saito S, Kurasaki M (2002) Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. Naunyn Schmiedeberg\u2019s Arch Pharmacol 365(4):277\u2013283. doi:10.1007\/s00210-001-0524-8","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"4","key":"55_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/PL00010320","volume":"18","author":"SW Schaffer","year":"2000","unstructured":"Schaffer SW, Lombardini JB, Azuma J (2000) Interaction between the actions of taurine and angiotensin II. Amino Acids 18(4):305\u2013318","journal-title":"Amino Acids"},{"issue":"1","key":"55_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.ASN.0000042803.28024.92","volume":"14","author":"DM Townsend","year":"2003","unstructured":"Townsend DM, Deng M, Zhang L, Lapus MG, Hanigan MH (2003) Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 14(1):1\u201310","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"55_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","volume":"334","author":"X Yao","year":"2007","unstructured":"Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334(2):115\u2013124. doi:10.1097\/MAJ.0b013e31812dfe1e. 00000441-200708000-00006 [pii]","journal-title":"Am J Med Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Taurine 10"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-024-1079-2_55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T13:18:31Z","timestamp":1709644711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-024-1079-2_55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789402410778","9789402410792"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-94-024-1079-2_55","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2017]]}}}